Clinical Practice, Diagnostic and Treatment Strategy
Dr. John Mascarenhas

Associate Professor of Medicine, Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Attending, Department of Medicine, Division of Hematology/Medical Oncology, Mount Sinai Medical Center, New York, New York, USA


 

Education

2007 - 2010

MS, Clinical Research, Mount Sinai Graduate School in Biological Sciences, New York, USA

2005 - 2008

Hematology-Oncology Fellow, Mount Sinai School of Medicine, New York, New York, USA

2002 - 2005

Internal Medicine Resident, Brown University School of Medicine, Providence, Rhode Island, USA

1998 - 2002

M.D., New York Medical College, Valhalla, New York, USA

1991 - 1995

B.S./B.A., State University of New York at Binghamton, New York, USA

 

Professional Experience

2019 - Present

Director, Adult Blood Cancer and Myeloid Disorders Center of Excellence (COE) at Mount Sinai Health System, New York, New York, USA

2018 - Present

Teaching Faculty, Graduate School of Biomedical Sciences of the Icahn School of Medicine at Mount Sinai, New York, New York, USA

2017 - Present

Director, Adult Leukemia Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA

2017   

Chair, American Society of Hematology Annual Meeting Abstract Review Committee, Myeloproliferative Disorder section         

2016  

Reviewer, American Society of Hematology Annual Meeting, Myeloproliferative Disorder section

2015 - Present

Editorial board, Haematologica

2014 - Present

Member Protocol Review and Monitoring Committee, Icahn School of Medicine at Mount Sinai, New York, New York, USA

2012 - 2014

Member, Accrual Monitoring Committee, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA

2011 - Present

Ad Hoc reviewer Blood, Leukemia, Leukemia Research, Leukemia and Lymphoma, British Journal of Haematology, New England Journal of Medicine, Lancet Hematology, Lancet Oncology, JAMA Oncology  

2009 - Present

Co-Chair, Hematological Malignancy Disease Focus Group. Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA

2009 - 2014

Alternate Member Protocol Review and Monitoring Committee, Mount Sinai School of Medicine, New York, New York, USA